Hyperacute Progression of Sinonasal NUT Carcinoma After Pembrolizumab‐Based Treatment: A Case Report
The Laryngoscope · 2026-12 · 136 (12) · 5312-5315
DOI: 10.1002/lary.70733 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Laryngoscope, online erschienen am 08.07.2026. Verfasst von Zhuomiao Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center (CRC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Carcinoma, Paranasal Sinus Neoplasms. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Science and Technology Innovation Key R&D Program of Chongqing, the Natural Science Foundation of Chongqing (Innovation and Development Joint Fund Project, The Natural Science Foundationof Chongqing.
Abstract (Originalsprache)
This case report describes hyperacute destructive progression of sinonasal NUT carcinoma with new osseous metastasis shortly after pembrolizumab-based immunochemotherapy. The clinical course highlights the importance of early NUT testing, proactive systemic surveillance, cautious interpretation of immunotherapy response, and timely consideration of BET inhibition or clinical trial referral.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center (CRC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
- Cancer Early Detection and Treatment Center (CEDTC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
- Department of Breast Surgery, Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
- Department of Nuclear Medicine, Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
- Medical Pathology Center (MPC), Chongqing University Three Gorges Hospital, Chongqing University, Chongqing, China.
- Chongqing University Three Gorges Hospital & Academy for Advanced Interdisciplinary Technology, CQU - Ferenc Krausz Nobel Laureate Scientific, Chongqing, China.
ORCID-Profile: Zhuomiao Ye
Förderung
- Science and Technology Innovation Key R&D Program of Chongqing
- the Natural Science Foundation of Chongqing (Innovation and Development Joint Fund Project
- The Natural Science Foundationof Chongqing
Zitieren
APA
Ye, Z., Yang, D., Xie, F., Zhang, M., Gao, C., Xie, Y., Li, X., & Yin, M. (2026). Hyperacute Progression of Sinonasal NUT Carcinoma After Pembrolizumab‐Based Treatment: A Case Report. The Laryngoscope, 136(12), 5312-5315. https://doi.org/10.1002/lary.70733
Vancouver
Ye Z, Yang D, Xie F, Zhang M, Gao C, Xie Y, et al. Hyperacute Progression of Sinonasal NUT Carcinoma After Pembrolizumab‐Based Treatment: A Case Report. The Laryngoscope. 2026;136(12):5312-5315. doi:10.1002/lary.70733
BibTeX
@article{Ye2026,
author = {Ye, Zhuomiao and Yang, Dan and Xie, Fei and Zhang, Minghui and Gao, Cailiang and Xie, Yunjin and Li, Xin and Yin, Mingzhu},
title = {Hyperacute Progression of Sinonasal NUT Carcinoma After Pembrolizumab‐Based Treatment: A Case Report},
journal = {The Laryngoscope},
year = {2026},
volume = {136},
number = {12},
pages = {5312--5315},
doi = {10.1002/lary.70733}
}
EUVIMED